Skip to main navigation menu Skip to main content Skip to site footer

No. nr 1–2 (2023)

Artykuły

Health Security Committee as EU Planning Body for Prevention of Serious Cross-Border Health Threats in European Union Countries]

DOI: https://doi.org/10.52097/eppism.8648  [Google Scholar]
Published: 2024-05-15

Abstract

The aim of the article is to present the current legal status in the European Union system in the field of responding to serious cross-border health threats. The article focuses on organizational issues, describing the objectives, tasks and compe- tences of the Health Security Committee as a key body in the field of coordination of planning, prevention of serious cross-border threats to health. This body, previously established by the Decision of the European Parliament and of the Council of 22 October 2013 has been substantially reorganized and equipped with additional competences. Its activities have been linked to other European Union institutions, namely the Committee on Serious Cross-border Health Threats, Health Emergency Preparedness and Response Authority, and the Health Crisis Board and the Health Task Force. However, technical issues related to the functioning of reference laboratories and the digital surveillance platform, as well as issues related to creation of national and EU plans for prevention, preparedness and response, were omitted in the document.

References

  1. Baumann-Popczyk A., Wirusowe zapalenie wątroby typu E jako zoonoza, „Przegląd Epidemiologiczny”, 2011, 65. [Google Scholar]
  2. Bugajski R., Poważne transgraniczne zagrożenie zdrowia (projekt UE), LEX/el2022. [Google Scholar]
  3. Dąbrowska-Kłosińska P., Stosowanie unijnych przepisów o transgranicznych zagrożeniach dla zdrowia a ochrona danych osobowych w UE, „Przegląd Prawa i Administracji”, 2016, 107. [Google Scholar]
  4. Gołda-Sobczak M., Strategia farmaceutyczna dla Europy – pokłosie pandemii Sars-CoV-2 [w:] J. Sobczak, A. Rogacka-Łukasik (red.) Wybrane zagadnienia prawa medycznego wobec wyzwań pandemii wywołanej wirusem Sars-CoV-2, Częstochowa–Poznań 2022. [Google Scholar]
  5. Lachassinne E., de Pontual L., Caseris M., Lorrot M., Guilluy C., Naud A., Dommergues M.-A., Pinquier D., Wannepain E., Hausherr E., Jung C., Gajdos V., Cohen R., Zahar J.-R., Brichler S., Basmaci R., Boelle P.-Y., Bloch-Queyrat C., Aupiais C., SARS-CoV-2 transmission among children and Staff in daycare centers during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study, „Lancet Child Adolesc Health”, 2021, 5. [Google Scholar]
  6. Laxminarayan R., Wahl B., Dudala S.R., Gopal K., Mohan Ch., Neelima S., Jawahar Reddy K.S., Radhakrishnan J., Lewnard J.A., Epidemiology and transmission dynamics of COVID-19 in two Indian states, „Science”, 2020, 370. [Google Scholar]
  7. Lee B., Raszka W.V. Jr. COVID-19 transmission and children: The child is not to blame, „Pediatrics”, 2020, 146. [Google Scholar]
  8. Sobczak J., Zdrowie publiczne a prawa pacjentów w transgranicznej opiece zdrowotnej [w:] M. Urbaniak, R. Staszewski (red.) Aktualne problemy przemian systemu ochrony zdrowia w Polsce, Poznań 2017. [Google Scholar]
  9. Sobczak J., Poważne transgraniczne zagrożenie zdrowia w systemie prawa unijnego [w:] T. Gardocka, A. Fiutak, D. Jagiełło (red.) Aktualne problemy prawne w psychologii i medycynie, Warszawa 2018. [Google Scholar]
  10. Truszczyński M., Samorek-Salamonowicz E., Ocena zoonotycznego potencjału grypy ptaków i świń jako źródła wirusów chorobotwórczych dla człowieka, „Nauka”, 2010, 1. [Google Scholar]

Most read articles by the same author(s)